Pharmas sued for alleged scheme to fix prices of antidepressant

Charles McConnell

04 April 2017

A healthcare benefits fund based in New York filed a putative class action against several pharmaceutical companies on Friday for allegedly conspiring to raise the prices of generic amitriptyline, a tricyclic antidepressant tablet.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Charles McConnell

View full biography

Author | Senior reporter, Global Competition Review

[email protected]

Tipline

End of the FTC as we know it: The Tipline for 27 January 2023
The Federal Trade Commission may cease to exist as it does today if it continues down its current path, Christine Wilson has said. The FTC’s sole Republican commissioner told a largely chummy audience at George Mason University yesterday that there are some “shocking things” going on behind the scenes at the agency, suggesting that the Bureau of Competition may inevitably find its powers consolidated down the block at Main Justice. Also in Tipline, Dechert …
Bridging troubled waters: The Tipline for 26 January 2023
Don’t blame me: The Tipline for 25 January 2023